Raymond James & Associates lifted its stake in shares of Nu Skin Enterprises (NYSE:NUS) by 37.1% during the 4th quarter, Holdings Channel reports. The firm owned 20,909 shares of the company’s stock after acquiring an additional 5,656 shares during the period. Raymond James & Associates’ holdings in Nu Skin Enterprises were worth $1,427,000 at the end of the most recent reporting period.
Other institutional investors also recently made changes to their positions in the company. Jennison Associates LLC bought a new stake in shares of Nu Skin Enterprises during the 4th quarter valued at approximately $1,745,000. APG Asset Management N.V. grew its holdings in shares of Nu Skin Enterprises by 159.2% during the 4th quarter. APG Asset Management N.V. now owns 402,500 shares of the company’s stock valued at $22,870,000 after purchasing an additional 247,200 shares during the last quarter. Virtu Financial LLC bought a new stake in shares of Nu Skin Enterprises during the 4th quarter valued at approximately $220,000. Schwab Charles Investment Management Inc. grew its holdings in shares of Nu Skin Enterprises by 10.0% during the 3rd quarter. Schwab Charles Investment Management Inc. now owns 332,108 shares of the company’s stock valued at $20,418,000 after purchasing an additional 30,285 shares during the last quarter. Finally, Janus Henderson Group PLC grew its holdings in shares of Nu Skin Enterprises by 251.6% during the 3rd quarter. Janus Henderson Group PLC now owns 110,400 shares of the company’s stock valued at $6,787,000 after purchasing an additional 79,000 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors.
Several brokerages recently issued reports on NUS. Deutsche Bank lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating and set a $77.00 price target on the stock. in a report on Friday. Pivotal Research reaffirmed a “buy” rating and set a $90.00 price target on shares of Nu Skin Enterprises in a report on Friday, February 16th. Stifel Nicolaus lifted their price target on shares of Nu Skin Enterprises from $50.00 to $57.00 and gave the company a “sell” rating in a report on Friday, February 16th. ValuEngine raised shares of Nu Skin Enterprises from a “buy” rating to a “strong-buy” rating in a report on Monday, April 2nd. Finally, Zacks Investment Research lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Wednesday, February 28th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Hold” and an average price target of $71.29.
In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 4th. The shares were sold at an average price of $75.00, for a total transaction of $150,000.00. Following the sale, the general counsel now directly owns 47,878 shares of the company’s stock, valued at approximately $3,590,850. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Pisano R. Thomas sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 7th. The stock was sold at an average price of $72.00, for a total transaction of $1,080,000.00. Following the sale, the director now directly owns 47,437 shares in the company, valued at $3,415,464. The disclosure for this sale can be found here. Insiders have sold a total of 141,843 shares of company stock worth $10,393,337 over the last three months. Insiders own 5.20% of the company’s stock.
NUS opened at $71.23 on Tuesday. Nu Skin Enterprises has a fifty-two week low of $52.88 and a fifty-two week high of $76.24. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.17 and a current ratio of 1.74. The company has a market cap of $3,745.25, a price-to-earnings ratio of 22.05, a price-to-earnings-growth ratio of 2.06 and a beta of 1.35.
Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Thursday, February 15th. The company reported $1.20 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.19 by $0.01. Nu Skin Enterprises had a net margin of 5.68% and a return on equity of 25.23%. The firm had revenue of $666.20 million for the quarter, compared to analyst estimates of $667.39 million. During the same period in the previous year, the firm posted $0.79 EPS. The company’s revenue for the quarter was up 25.4% compared to the same quarter last year. equities research analysts forecast that Nu Skin Enterprises will post 3.56 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2018/04/17/raymond-james-associates-increases-position-in-nu-skin-enterprises-nus.html.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises (NYSE:NUS).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.